Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
| (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.60%2.54B | -9.68%626.65M | -4.14%560.73M | -15.00%579.05M | -8.95%769.48M | 3.75%2.81B | -9.11%693.83M | -15.52%584.94M | -17.97%681.22M | 1.13%845.08M |
| Cost of revenue | -14.22%1.23B | |||||||||
| Gross profit | -8.03%1.17B | |||||||||
| Operating expense | -12.44%2.09B | -10.94%516.08M | -3.11%488.63M | -24.60%463.95M | -9.69%623.31M | 56.76%2.39B | -16.93%579.45M | -14.94%504.31M | -8.11%615.32M | -4.34%690.21M |
| Staff costs | ---- | ---- | ---- | ---- | ---- | -0.79%437.81M | ---- | ---- | ---- | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | ---- | ---- | -10.22%34.14M | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | ---- | -10.22%34.14M | ---- | ---- | ---- | ---- |
| Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -2.58%482.04M | ---- | ---- | ---- | ---- |
| -Depreciation | ---- | ---- | ---- | ---- | ---- | -2.58%482.04M | ---- | ---- | ---- | ---- |
| Rent and land expenses | ---- | ---- | ---- | ---- | ---- | -16.45%69.3M | ---- | ---- | ---- | ---- |
| Other operating expenses | -8.76%2.49B | -9.47%612.95M | -5.69%563.42M | -10.51%619.49M | -8.95%697.9M | 473.43%2.73B | -2.94%677.04M | -15.50%597.4M | -9.18%692.26M | -4.23%766.48M |
| Total other operating income | 16.84%401.79M | -0.74%96.87M | -19.65%74.79M | 102.15%155.55M | -2.21%74.59M | 3,504.74%343.89M | --97.59M | -18.43%93.08M | -16.88%76.94M | -3.27%76.28M |
| Operating profit | 6.77%443.93M | -3.33%110.57M | -10.59%72.09M | 74.64%115.1M | -5.62%146.17M | 263.77%415.79M | 73.70%114.38M | -19.04%80.63M | -59.02%65.91M | 35.67%154.88M |
| Net non-operating interest income (expenses) | 10.84%-270.01M | 7.69%-60.5M | 5.72%-65.46M | 16.73%-71.01M | 11.56%-73.04M | 9.86%-302.83M | 20.96%-65.53M | 15.20%-69.43M | -3.12%-85.28M | 4.36%-82.59M |
| Non-operating interest income | -17.65%30.9M | 29.14%10.32M | -27.40%5.44M | -30.77%6.98M | -31.74%8.16M | -15.51%37.52M | -36.42%7.99M | -31.67%7.49M | -11.43%10.09M | 3.00%11.96M |
| Non-operating interest expense | -11.59%300.91M | -3.68%70.81M | -7.83%70.9M | -18.22%77.99M | -14.11%81.2M | -10.52%340.35M | -22.99%73.52M | -17.15%76.92M | 1.36%95.37M | -3.48%94.54M |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -31.06%901K | |||||||||
| Income from associates and other participating interests | -16.86%7.64M | -32.62%1.42M | -58.88%523K | 10.83%2.76M | -11.52%2.93M | -40.23%9.19M | 16.36%2.11M | -42.57%1.27M | -70.43%2.49M | 13.53%3.32M |
| Special income (charges) | 2.74%-189.06M | 10.75%-168.65M | 0 | -277.00%-20.4M | -323.55%-194.37M | -125.13%-188.96M | 0 | 70.19%-5.41M | 0 | |
| Less:Impairment of capital assets | 41.74%189.06M | 31.80%168.65M | --0 | ---- | ---- | 30.65%133.38M | --127.97M | --0 | ---- | ---- |
| Less:Other special charges | ---- | ---- | ---- | 277.00%20.4M | ---- | 57.55%-23.85M | 126.65%190.24M | ---- | -70.19%5.41M | ---- |
| Less:Write off | --0 | --0 | ---- | ---- | ---- | --61M | --61M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -1.25%724.42M | 24.40%89.17M | ||||||||
| Income before tax | 89.63%-7.49M | 15.10%-117.16M | -42.62%7.16M | 218.68%26.45M | 0.60%76.06M | -162.63%-72.21M | -401.87%-138M | -37.41%12.47M | -132.59%-22.29M | 38.77%75.61M |
| Income tax | 22.03%67.09M | -60.28%10.09M | 96.94%15.01M | 246.20%11.59M | 1.75%30.4M | -23.12%54.98M | 42.76%25.41M | -39.86%7.62M | -130.91%-7.93M | 94.06%29.88M |
| Net income | 41.36%-74.58M | 22.13%-127.25M | -261.71%-7.85M | 203.49%14.86M | -0.16%45.66M | -539.67%-127.19M | -189.03%-163.41M | -15.60%4.85M | -134.59%-14.36M | 19.73%45.73M |
| Net income continuous operations | 41.36%-74.58M | 22.13%-127.25M | -261.71%-7.85M | 203.49%14.86M | -0.16%45.66M | -390.41%-127.19M | -260.78%-163.41M | -33.12%4.85M | -133.60%-14.36M | 16.99%45.73M |
| Net income discontinuous operations | ---- | ---- | ---- | ---- | ---- | 99.98%-3K | 100.12%14K | 99.60%-6K | --0 | 98.77%-11K |
| Noncontrolling interests | -31.58%-33.11M | -43.55%-51.84M | 32.45%-1.63M | 179.92%4.84M | -20.08%15.52M | -152.29%-25.16M | -839.41%-36.11M | -168.16%-2.41M | -127.31%-6.06M | 10.91%19.42M |
| Net income attributable to the company | 59.35%-41.47M | 40.76%-75.41M | -185.58%-6.22M | 220.67%10.02M | 14.55%30.14M | -431.78%-102.03M | -107.25%-127.3M | 228.78%7.27M | -142.95%-8.31M | 27.21%26.31M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 59.35%-41.47M | 40.76%-75.41M | -185.58%-6.22M | 220.67%10.02M | 14.55%30.14M | -431.78%-102.03M | -107.25%-127.3M | 228.78%7.27M | -142.95%-8.31M | 27.21%26.31M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 59.35%-0.0361 | 40.79%-0.0656 | -185.71%-0.0054 | 220.83%0.0087 | 14.41%0.0262 | -431.74%-0.0888 | -107.10%-0.1108 | 231.58%0.0063 | -142.86%-0.0072 | 27.22%0.0229 |
| Diluted earnings per share | 59.35%-0.0361 | 40.79%-0.0656 | -185.71%-0.0054 | 220.83%0.0087 | 14.41%0.0262 | -431.74%-0.0888 | -107.10%-0.1108 | 231.58%0.0063 | -142.86%-0.0072 | 27.22%0.0229 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.